MINE More news Historic earnings coming! MINERC
Post# of 103062
MINERCO RETAINS INVESTOR RELATIONS PARTNERS AS INVESTOR RELATOINS COUNSEL
Press Release | 03/03/2021
MINERCO RETAINS INVESTOR RELATIONS PARTNERS
AS INVESTOR RELATOINS COUNSEL
ANN ARBOR, MI / March 3, 2021 /Minerco (OTC: MINE) today announced that it has retained Investor Relations Partners (IRP) to provide investor relations and capital markets advisory services to the Company.
We believe the current year will be one of the most historical for the psilocybin mushroom industry and, as a result, the most pivotal for Minerco and its shareholders, said Julius Jenge, Chief Executive Officer of Minerco, Inc. This favorable economic and business climate will create a unique opportunity for Minerco to achieve record growth rates and we will look forward towards the support and guidance of Investor Relations Partners to effectively communicate this growth story to the investment community.
We have a number of positive developments at Minerco,particularly as they relate to our plans on increasing our psilocybin tablet production capacity to be able to meet the highly anticipated demand for our mushroom products as markets across the United States begin to legalize it, just as they did with cannabis. In addition, we recently announced the launch of our blockchain token SHRU and its payment application SHRUCOIN Pay. These innovations can be used to purchase psilocybin and cannabis, concluded Mr. Jenge.
IRPs primary function will be to help disseminate and maintain contact with the financial community, including shareholders, investors and other stakeholders for the purpose of increasing awareness of the Company, its activities and to ensure the most accurate information is consistently being communicated as it relates to Minercos growth story.
Bill Miller of Investor Relations Partners, said, We are looking forward to introducing Minercos investment story beyond its existing shareholders as we look to increase and diversify its ownership structure. We expect Minerco will appeal to both value and earnings growth retail and institutional investors given our belief the company is undervalued when considering the pent-up and growing demand for the companys unique and proprietary psilocybin mushroom products, or more commonly referred to as a "Magic Mushrooms''. The companys position at the forefront of the movement to legalize psilocybin should enable Minerco to generate significant revenue growth and profitability as it continues to successfully execute on its business plan, concluded Mr. Miller.